South Africa’s intellectual property developments – heading in the wrong direction?
Pugatch Consilium’s Prof. Meir Pugatch and Consultant Jacques Stemmet publish an article in the Financial Times’ fDi Magazine, discussing the future of South Africa’s intellectual property environment and its impact on access to medicines and pharmaceutical FDI.
Professor Meir Pugatch Portuguese Interview: Brazil will have economic and social benefits to the development of biotechnology
Expert at the University of Haifa (Israel) has presented on Tuesday (29/April/2014), a recent study on the biotechnology market in eight countries: Full article in Portuguese
New Report on the Value of Cross-Border Data
Pugatch Consilium has launched a new report, At the Cutting Edge, on the benefits of cross-border data to consumers, companies and governments. The report considers the value and applications of cross-border data in different countries around the world today. It analyzes a wide range of personal, social and economic benefits using case studies and anecdotes as well as statistical analysis. The report also presents a set of enabling and deterrent factors of these flows. Download a copy from the Research & Analysis Reports page.
Intellectual Property: Bristol-Myers Squibb and the Medicines Patent Pool – An Unlikely Marriage?
The Role of the Medicines Patent Pool in Stimulating the Development and Availability of Global Health Medicines. Full article at the Lexxion Website
On Intellectual Property, A New Strategy
India could use IP rights to take its rightful place as a leader in global innovation. Read the full article written by Professor Meir Pugatch at The Indian Express
When National Champions Fall
The case of Teva requires us to revise our thinking about national champions and national interests;
Prof. Meir Perez Pugatch addresses the current situation with Teva pharmaceuticals – the biggest generics company in the world – in Israel and how it has been impacted by the patent expiration of Copaxon. Full article at Pharmaphorum Media
Professor Meir Pugatch at the Montréal InVivo/LSO – Breakfast round-table IP protection – Ottawa
Prof. Meir Pugatch presenting at the Montréal InVivo/LSO – Breakfast round-table IP protection in Ottawa
Full video at: http://www.youtube.com/watch?v=IkmC5DQ5b88&feature=youtu.be
Innovative Drug Research & Development in Russia Conference
Prof. Pugatch will be moderating the regulatory panel on: Government support, strategies and policies for promoting R&D, at the 4th Annual “Innovative Drug Research & Development in Russia” Conference, 19 November 2013
Rule of Law
Pugatch Consilium and the Coalition for the Rule of Law in Global Markets Introduce the Global Business Rule of Law Dashboard at the AACCLA’s 46th Annual Meeting -Forecast on Latin America and the Caribbean” Conference, 30 September 2013 View the Presentation
More Voices Enter Clinical Trials Data Sharing Debate in Europe
Pugatch Consilium’s paper released last week, receives an overview by PhRMA! Read more at: http://phrma.org/catalyst/more-voices-clinical-trials-data-sharing-debate-europe
Pugatch Consilium provides evidence-based intelligence that helps clients in the fastest growing sectors optimise their performance Continue reading »
July 29, 2014
Pugatch Consilium’s Prof. Meir Pugatch and Consultant Jacques Stemmet publish ... Read more →
May 26, 2014
Pugatch Consilium Partner, Dr Torstensson presented the main findings of ... Read more →